Tweet
Action plan on antibiotic resistance
In 29 countries in the Region, an estimated 25 000 people die each year from infections related to antibiotic resistance, most of them contracted in health care settings. The social, economic and health care costs are equally alarming: US$ 1.5 billion annually is spent on extra hospital treatment alone.
The European strategic action plan on antibiotic resistance was warmly welcomed as a means of harnessing the existing initiatives, policies, tools, plans and expertise already available to address this increasing threat in a coordinated manner. In particular, the synergistic role of the action plan in boosting the implementation of the WHO Global Strategy for Containment of Antimicrobial Resistance was made explicit in the resolution as adopted by the delegates.
The action plan proposes several key actions to mitigate, prevent and control antibiotic resistance, including promoting national coordination to implement national action plans; promoting the prudent use of antibiotics; strengthening surveillance of the use of antibiotics and resistant bacteria; and creating awareness of the prudent use of antibiotics and the fact that new antibiotic drugs are not coming onto the market soon.
Action plan on multidrug-resistant and extensively drug-resistant tuberculosis
An estimated 81 000 people have multidrug-resistant tuberculosis (TB) in the European Region, and only 62% of the people with confirmed multidrug-resistant TB receive adequate treatment. An unacceptably large number therefore receive inadequate treatment or are on waiting lists. The goal of the action plan set before countries today is to contain the spread of drug-resistant TB by achieving universal access to prevention, diagnosis and treatment of multidrug-resistant and extensively drug-resistant TB in all countries in the Region by 2015.
In plenary, countries welcomed the plan, noting the importance of its focus on addressing barriers to treatment and reaching socially marginalized groups. A delegate from Azerbaijan stated, ?This is only the start of a long and difficult journey ? we cannot just throw medical treatment at the problem but ensure that diagnosis and treatment is more widespread, better accepted and followed?. Countries adopted the plan.
WHO
thanks to TeamLeiden and Resistentie
In 29 countries in the Region, an estimated 25 000 people die each year from infections related to antibiotic resistance, most of them contracted in health care settings. The social, economic and health care costs are equally alarming: US$ 1.5 billion annually is spent on extra hospital treatment alone.
The European strategic action plan on antibiotic resistance was warmly welcomed as a means of harnessing the existing initiatives, policies, tools, plans and expertise already available to address this increasing threat in a coordinated manner. In particular, the synergistic role of the action plan in boosting the implementation of the WHO Global Strategy for Containment of Antimicrobial Resistance was made explicit in the resolution as adopted by the delegates.
The action plan proposes several key actions to mitigate, prevent and control antibiotic resistance, including promoting national coordination to implement national action plans; promoting the prudent use of antibiotics; strengthening surveillance of the use of antibiotics and resistant bacteria; and creating awareness of the prudent use of antibiotics and the fact that new antibiotic drugs are not coming onto the market soon.
Action plan on multidrug-resistant and extensively drug-resistant tuberculosis
An estimated 81 000 people have multidrug-resistant tuberculosis (TB) in the European Region, and only 62% of the people with confirmed multidrug-resistant TB receive adequate treatment. An unacceptably large number therefore receive inadequate treatment or are on waiting lists. The goal of the action plan set before countries today is to contain the spread of drug-resistant TB by achieving universal access to prevention, diagnosis and treatment of multidrug-resistant and extensively drug-resistant TB in all countries in the Region by 2015.
In plenary, countries welcomed the plan, noting the importance of its focus on addressing barriers to treatment and reaching socially marginalized groups. A delegate from Azerbaijan stated, ?This is only the start of a long and difficult journey ? we cannot just throw medical treatment at the problem but ensure that diagnosis and treatment is more widespread, better accepted and followed?. Countries adopted the plan.
WHO
thanks to TeamLeiden and Resistentie